7Baggers
Quarterly
Annual
    Unit: USD2025-09-27 2025-06-28 2025-03-29 2024-12-28 2024-09-28 2024-06-29 2024-03-30 2023-12-30 2023-09-30 2022-12-31 2022-10-01 2022-07-02 2022-04-02 2022-01-01 2021-10-02 2021-07-03 2021-04-03 2021-01-02 2020-09-26 2020-06-27 2020-03-28 2019-12-28 2019-09-28 2019-06-29 2019-03-30 2018-12-29 2018-09-29 2018-06-30 2018-03-31 
      
    		                             
      cash flows from operating activities
    		                             
      net income
    		88,600,000 63,100,000 68,300,000 41,100,000 55,100,000 77,600,000 46,100,000 69,100,000 85,500,000 90,100,000 56,000,000 59,100,000 37,300,000 71,100,000 78,000,000 105,800,000 76,400,000 32,500,000 45,600,000 -28,000,000 39,900,000 25,400,000 37,400,000 26,500,000 604,800,000 82,500,000 66,700,000 92,600,000 29,300,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                             
      depreciation and amortization
    		53,600,000 53,300,000 52,200,000 54,100,000 53,700,000 54,500,000 54,600,000 55,000,000 54,000,000 53,100,000 53,200,000 55,800,000 55,100,000 55,200,000 54,700,000 56,900,000 55,800,000 55,400,000 53,600,000 54,700,000 54,900,000 54,800,000 55,100,000 56,200,000 56,100,000 55,200,000 53,700,000 54,600,000 55,000,000 
      foreign exchange and other non-cash financing income
    		-7,700,000 -4,400,000 -8,200,000                           
      share-based compensation expense
    		6,700,000 9,600,000 6,100,000 8,600,000 6,400,000 5,200,000 8,600,000 7,800,000 3,300,000 9,500,000 7,200,000 3,500,000 24,100,000 6,100,000 5,700,000 6,500,000 6,300,000 6,300,000 4,900,000 5,700,000 2,900,000 4,500,000 4,100,000 3,800,000 2,600,000 500,000 2,300,000 1,600,000 1,600,000 
      decrease in post-employment benefit obligations
    		-8,700,000 -1,400,000 -3,000,000 -2,400,000 -2,400,000 -2,000,000 -2,200,000 -2,900,000 -1,900,000 -4,500,000 -3,600,000 -3,300,000 -4,600,000 -2,800,000 -4,300,000 -3,400,000 -4,200,000 -4,300,000 -4,700,000 -1,600,000 -1,800,000 -3,000,000 -1,900,000 -2,100,000 -2,400,000 -2,100,000 -600,000 -700,000 -1,200,000 
      deferred income taxes
    		4,700,000 -7,900,000 -3,100,000 13,000,000 -11,900,000 -12,100,000 -1,100,000 -26,500,000 -16,900,000 -26,500,000 -22,400,000 -18,500,000 -12,300,000 -48,300,000 -11,800,000 -24,600,000 -9,600,000 -7,400,000 -28,700,000 -15,300,000 3,700,000 -12,800,000 -17,400,000 6,200,000 -624,400,000 -20,900,000 -5,700,000 -27,200,000 -11,100,000 
      asset impairments
    		400,000 200,000 600,000     0  1,200,000 500,000   1,900,000 0   100,000 1,400,000           
      loss on deconsolidation of russian entity
    		                             
      gain on disposal of property, plant and equipment
    		   -100,000 0                         
      other operating activities
    		-1,100,000 3,200,000 2,600,000 1,400,000 -300,000 3,600,000 -4,800,000 1,300,000 500,000 1,900,000 400,000 1,200,000 3,100,000 -1,900,000 1,800,000 1,800,000 2,000,000 2,200,000 2,800,000 1,400,000 2,700,000 2,600,000 -300,000 1,300,000 2,400,000 2,100,000 100,000 600,000 800,000 
      changes in operating assets and liabilities:
    		                             
      —accounts receivable
    		-7,900,000 -16,200,000 -47,300,000 54,500,000 10,800,000 -18,200,000 -38,700,000                       
      —inventories
    		9,700,000 -1,000,000 -15,400,000 20,000,000 -18,000,000 -29,100,000 -36,900,000                       
      —accounts payable
    		-24,200,000 -19,800,000 3,100,000 -2,600,000 -21,800,000 -2,800,000 -400,000                       
      —prepaid expenses and other assets
    		13,900,000 9,300,000 -22,300,000 19,100,000 4,600,000 9,900,000 3,700,000                       
      —taxes payable
    		-29,100,000 -10,100,000 8,500,000 1,700,000 -1,200,000 900,000 -2,300,000                       
      —other liabilities
    		-1,100,000 25,100,000 -34,800,000 600,000 42,400,000 14,300,000 -36,500,000                       
      net cash from operating activities
    		98,000,000 103,000,000 7,300,000 190,900,000 115,900,000 93,800,000 -21,000,000 189,300,000 107,800,000 247,000,000 100,600,000 23,600,000 -105,400,000 168,900,000 101,700,000               
      capex
    		-17,500,000 -19,400,000 -17,500,000 -23,300,000 -21,900,000 -21,900,000 -16,000,000 -21,600,000 -15,200,000 -18,600,000 -24,100,000 -17,500,000 -17,400,000 -21,300,000 -16,100,000               
      free cash flows
    		80,500,000 83,600,000 -10,200,000 167,600,000 94,000,000 71,900,000 -37,000,000 167,700,000 92,600,000 228,400,000 76,500,000 6,100,000 -122,800,000 147,600,000 85,600,000               
      cash flows from investing activities
    		                             
      purchases of property, plant and equipment
    		-17,500,000 -19,400,000 -17,500,000 -23,300,000 -21,900,000 -21,900,000 -16,000,000 -21,600,000 -15,200,000 -18,600,000 -24,100,000 -17,500,000 -17,400,000 -21,300,000 -16,100,000 -22,200,000 -18,100,000 -19,200,000 -15,900,000 -11,000,000 -12,100,000 -21,600,000 -13,600,000 -15,600,000 -21,300,000 -23,100,000 -37,600,000 -49,500,000 -55,900,000 
      purchases of intangible assets
    		-7,300,000 -10,000,000 -8,700,000 -10,100,000 -6,100,000 -5,300,000 -2,100,000 -2,600,000 -2,200,000 -2,700,000 -3,500,000 -2,600,000 -600,000 -1,700,000 -3,900,000 -1,600,000 -2,100,000 -2,600,000 -2,100,000 -1,700,000 -2,800,000 -3,000,000 -2,800,000 -3,600,000 -1,600,000 -4,700,000 -3,100,000 -4,200,000 -4,600,000 
      purchases of investments
    		   0 -100,000                         
      cash paid under company-owned life insurance policies
    		0 -3,400,000 -7,000,000 0 -1,300,000 0 -4,100,000                       
      cash received under company-owned life insurance policies
    		0 1,900,000 500,000 3,300,000 1,200,000 7,300,000 2,700,000                       
      proceeds from the sale of property, plant and equipment
    		100,000 100,000 2,000,000 1,000,000 500,000   400,000 400,000                 -300,000    
      cash deconsolidated from previously controlled subsidiary
    		   0                          
      other investing activities
    		-200,000 -200,000 -300,000       700,000 0 900,000 300,000 7,600,000 600,000 1,400,000 200,000 -1,000,000 0 200,000 100,000 3,500,000 100,000   -1,400,000 -1,300,000 -300,000 -900,000 
      net cash from investing activities
    		-24,900,000 -31,000,000 -31,000,000 -24,100,000 -40,200,000 -20,600,000 -19,500,000 -23,800,000 -16,900,000 -19,200,000 -28,900,000 -17,600,000 -25,000,000 -15,400,000 -20,000,000 -21,400,000 -29,200,000 -23,900,000 -16,500,000 -12,500,000 -24,600,000 -8,400,000 -22,100,000 -15,800,000 -31,700,000 -29,500,000 -40,400,000 -104,300,000 -69,400,000 
      cash flows from financing activities
    		                             
      issuance of shares
    		5,100,000 2,900,000 1,800,000 4,900,000 2,900,000 4,600,000 2,500,000 1,200,000 800,000 800,000 1,200,000 13,700,000 200,000 300,000 600,000 2,000,000 1,700,000 300,000 100,000           
      repurchase of shares
    		0 0 -13,000,000 0 -125,800,000 0 -50,300,000                       
      proceeds from long-term debt
    		   0 40,000,000   0 0 575,000,000 0 0 70,000,000                 
      payments of long-term debt
    		-104,700,000 -4,700,000 -4,700,000 -31,400,000 -10,000,000 -1,802,100,000 -104,900,000 -4,900,000 -104,900,000 -631,400,000 -35,200,000 -5,000,000 -5,300,000 -5,300,000 -5,300,000 -74,900,000 -5,500,000 -312,600,000 -6,200,000 -6,200,000 -6,200,000 -574,200,000 0 -6,200,000 -12,700,000 0 -6,800,000 -6,600,000 -920,100,000 
      debt issuance costs paid
    		   -1,100,000 -2,800,000   -900,000 -100,000 -23,000,000 0 -200,000 -100,000 -3,100,000 0 -800,000 -7,800,000 0 0 0 -300,000         
      employee taxes paid from shares withheld
    		-3,200,000 -5,400,000 -11,500,000                           
      dividends paid to non-controlling interests
    		-3,000,000 -1,200,000 -2,300,000 -11,300,000    -17,700,000  0 -14,200,000   -13,100,000 -3,200,000   -5,500,000 -3,600,000   -4,300,000 -9,500,000 -13,200,000 -1,800,000 -11,900,000 -7,100,000   
      other financing activities
    		4,300,000 -400,000 5,100,000 5,700,000 1,500,000 6,500,000 3,800,000 5,700,000 23,400,000 2,600,000 -1,500,000 -4,900,000 -5,400,000 -2,800,000 -3,200,000 -3,800,000 -3,500,000 -4,300,000 -3,100,000 -500,000 1,500,000 -500,000 600,000 800,000 200,000 0 -200,000 -300,000 6,200,000 
      net cash from financing activities
    		-101,500,000 -8,800,000 -24,600,000 -33,200,000 -95,900,000 -8,700,000 -148,900,000 -16,600,000 -81,300,000 -76,100,000 -49,700,000 -11,500,000 -115,800,000 -34,600,000 -11,100,000 -87,800,000 -15,100,000 -322,100,000 -12,800,000 -16,000,000 -2,900,000 -19,200,000 -8,800,000 -18,200,000 -13,100,000 -11,800,000 -14,100,000 -28,000,000 -145,000,000 
      effect of exchange rate changes on cash and cash equivalents and restricted cash
    		-2,100,000 16,500,000 6,600,000 -26,300,000 14,800,000 -7,300,000 -8,900,000 15,000,000 -17,700,000 31,300,000 -19,900,000 -8,200,000 -4,700,000 -1,300,000 -3,300,000 -600,000 -5,800,000 13,900,000 7,400,000 1,400,000 -12,900,000 3,200,000 -5,400,000 -200,000 2,800,000 -3,200,000 -2,800,000 -11,500,000 5,100,000 
      net increase in cash and cash equivalents and restricted cash
    		-30,500,000      -198,300,000        67,300,000   -150,600,000 34,000,000   179,300,000    126,700,000   -235,800,000 
      cash and cash equivalents and restricted cash at the beginning of the period
    		0 0 684,800,000 0 0 0 724,000,000 0 0 0 0 0 660,900,000 0 0 0 524,100,000 0 0 0 636,600,000 0 0 0 424,600,000 0 0 0 566,000,000 
      cash and cash equivalents and restricted cash at the end of the period
    		-30,500,000 79,700,000 643,100,000 107,300,000 -5,400,000 57,200,000 525,700,000 163,900,000 -8,100,000 183,000,000 2,100,000 -13,700,000 410,000,000 117,600,000 67,300,000 26,000,000 450,000,000 -150,600,000 34,000,000 13,400,000 627,300,000 179,300,000 45,100,000 77,300,000 334,900,000 126,700,000 -8,900,000 -23,400,000 330,200,000 
      supplemental schedule of cash flow information
    		                             
      interest paid
    		 20,300,000 36,500,000  18,700,000 40,500,000 45,500,000 29,300,000 49,200,000 23,500,000 37,800,000 19,800,000 37,600,000 20,500,000 38,700,000 22,200,000 39,800,000  48,300,000 23,000,000 25,500,000      40,900,000 28,100,000 73,400,000 
      income taxes paid
    		 35,000,000 19,700,000  27,100,000 24,900,000 36,500,000 39,600,000 22,900,000 20,100,000 29,000,000 39,100,000 29,600,000 24,300,000 22,200,000 15,000,000 21,500,000 23,100,000 20,700,000 -1,900,000 18,500,000 18,400,000 28,500,000 28,900,000 33,000,000 30,300,000 30,600,000 27,600,000 25,500,000 
      accrued capital expenditures
    		 -200,000 1,100,000  -400,000 -200,000 1,600,000 -800,000 -200,000 0 -600,000 2,000,000 500,000 500,000 -100,000 200,000 400,000 -100,000 200,000 -1,000,000 1,900,000 200,000 500,000 700,000 400,000 -1,500,000    
      net decrease in cash and cash equivalents and restricted cash
    		  -41,700,000  -5,400,000    -8,100,000        -74,100,000    -9,300,000   77,300,000 -89,700,000     
      loss on deconsolidation of russian subsidiary
    		   -100,000                          
      proceeds from sale of investments
    		                             
      foreign exchange and other non-cash financing incomes
    		    -14,300,000 -800,000 -11,100,000                       
      foreign exchange and other non-cash financing expenses
    		        13,300,000 -25,200,000 5,900,000 15,900,000 9,200,000 9,500,000 10,400,000 6,000,000 7,300,000             
      —change in accounts receivable
    		                             
      —change in inventories
    		                             
      —change in accounts payable
    		                             
      —change in prepaid expenses and other assets
    		                             
      —change in taxes payable
    		                             
      —change in other liabilities
    		                             
      cash paid under corporate-owned life insurance policies
    		        -1,200,000 0 -1,300,000 0 -10,300,000 0 -1,100,000 0 -10,100,000 -1,100,000 0 0 -9,800,000         
      cash received under corporate-owned life insurance policies
    		        1,300,000 1,400,000 0 1,600,000 3,000,000 0 500,000 1,000,000 900,000 0            
      buy-back of shares
    		        0  0 -600,000 -175,200,000                 
      —increase in accounts receivable
    		         17,900,000 6,300,000 -65,100,000 -88,400,000 101,600,000 37,100,000 -29,200,000 -131,800,000    -42,100,000  33,000,000 9,100,000 -46,100,000 33,000,000 26,000,000 -29,800,000 -78,800,000 
      —decrease (increase) in inventories
    		                     39,900,000 25,100,000       
      —decrease in accounts payable
    		                  15,700,000           
      —decrease (increase) in prepaid expenses and other assets
    		                 4,100,000            
      —decrease in taxes payable
    		                             
      —decrease in other liabilities
    		           -4,200,000 -38,800,000         -29,500,000 10,900,000 7,500,000 -32,400,000  -11,700,000 23,700,000 -50,800,000 
      —increase in accounts payable
    		         1,400,000 -11,600,000 2,900,000 -8,600,000 49,800,000 -16,400,000 37,000,000 29,200,000    19,500,000 42,200,000 -43,000,000 -21,600,000 -25,800,000 25,700,000 -31,800,000 24,900,000 23,300,000 
      —increase in taxes payable
    		         -1,400,000 4,800,000 -8,300,000 -19,500,000 3,600,000 7,000,000 21,000,000 7,100,000 -3,700,000 -8,700,000 2,600,000 -38,300,000 -2,000,000 -5,600,000 2,100,000 51,700,000 -8,900,000 -15,000,000 11,000,000 -2,400,000 
      —increase in other liabilities
    		         9,900,000    -16,300,000 12,400,000 16,100,000 -20,500,000 -7,000,000 -4,900,000 22,700,000 20,400,000         
      changes in operating assets and liabilities, net of effects of acquisitions:
    		                             
      —increase in inventories
    		          -10,500,000 -2,500,000 -37,800,000 -37,600,000 -69,500,000 -49,100,000 -36,200,000 -3,100,000 20,300,000 -11,800,000 -27,500,000    -21,300,000 -15,100,000 -28,000,000 -24,000,000 -29,000,000 
      —increase in prepaid expenses and other assets
    		          22,400,000 -13,800,000 -24,200,000 -23,000,000 -3,400,000 -9,100,000 -5,800,000   5,700,000 -6,100,000 27,200,000 -16,500,000 -900,000 -12,400,000 -2,900,000 -15,600,000 -7,700,000 -1,300,000 
      net increase in cash and cash equivalents
    		                             
      net decrease in cash and cash equivalents
    		           -13,700,000 -250,900,000                 
      adjustments to reconcile net income to net cash from operations:
    		                             
      net cash from operations
    		                -24,000,000 181,500,000 55,900,000 40,500,000 31,100,000 203,700,000 81,400,000 111,500,000 -47,700,000 171,200,000 48,400,000 120,400,000 -26,500,000 
      non-cash currency transaction gain on debt and hedging instruments
    		                 28,500,000 17,800,000 5,900,000 -5,300,000         
      premium paid on redemption of long-term debt
    		                         0 0 0 27,000,000 
      other net non-cash financing incomes
    		                 -18,300,000            
      —decrease (increase) in accounts receivable
    		                             
      purchase of businesses, net of cash acquired
    		                         0 0   
      other offering costs
    		                             
      interest paid, net of amount capitalized
    		                     38,300,000 32,500,000 28,600,000 51,400,000     
      other net non-cash financing costs
    		                   -5,100,000 8,200,000 -3,800,000 25,000,000 -6,900,000 13,100,000 10,700,000 11,400,000 37,100,000 6,400,000 
      issuance of shares, net of underwriting costs
    		                    2,100,000 100,000 100,000       
      non-cash currency transaction (gain) loss on debt and hedging instruments
    		                             
      non-cash currency transaction gain on net debt and hedging instruments
    		                      -24,500,000      4,700,000 
      net cash received (paid) under corporate-owned life insurance policies
    		                             
      net cash paid under corporate-owned life insurance policies
    		                       3,200,000 -8,800,000 0 0 600,000 -8,000,000 
      accrued deferred offering costs
    		                           -4,600,000 5,100,000 
      non-cash currency transaction (gain) loss on net debt and hedging instruments
    		                        -13,600,000 -10,500,000 -3,400,000   
      issue of shares, net of underwriting costs
    		                        1,200,000     
      impairments of intangibles and other assets
    		                             
      gain on disposal of businesses
    		                             
      issue of shares, net of cost of issuance
    		                          500,000 0 799,100,000 
      deferred offering costs
    		                          -500,000 -4,900,000 -3,200,000 
      non-cash accrued capital expenditures
    		                           700,000 2,600,000 
      dividend declared but not yet paid to non-controlling interests
    		                             
      decrease in restricted cash
    		                             
      purchase of subsidiaries, net of cash acquired
    		                             
      issue of shares
    		                             
      effect of exchange rate changes on cash and cash equivalents
    		                             
      cash and cash equivalents at beginning of period
    		                             
      cash and cash equivalents at the end of the period
    		                             
      supplemental schedule of cash flows
    		                             
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.